The first full approval for a COVID-19 vaccine has been awarded by the FDA. Pfizer and its German partner BioNTech’s vaccine, now marketed as Comirnaty, is now approved for people 16 and older. It will remain under an emergency status for adolescents aged 12 to 15. Pfizer was also first to receive an emergency approval last year. With its approval, it is expected that vaccine mandates from companies, universities and organizations will increase.
Click here to read the entire article.